Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349542 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
A Phase 4 study, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02349542 is a Phase 4 study that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT02349542, a Phase 4 study, has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the serum levels (pharmacokinetics) of bupivacaine in a series of patients undergoing simultaneous bilateral total knee arthroplasty with the use of a standardized periarticular injection containing free bupivacaine and liposomal bupivacaine.
Interventions
- DRUG Liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-11-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02349542
The ClinicalTrials.gov registry entry for NCT02349542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoCarolina Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liposomal bupivacaine is the first listed.
NCT02349542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02349542 about?
NCT02349542 is a clinical study titled "Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty". The purpose of this study is to evaluate the serum levels (pharmacokinetics) of bupivacaine in a series of patients undergoing simultaneous bilateral total knee arthroplasty with the use of a standardized periarticular injection containing free bupivacaine and liposomal bupivacaine.
What is the current status of trial NCT02349542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2015-01. Estimated completion is 2016-11-21.
What interventions are being tested in trial NCT02349542?
The interventions under investigation include: Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02349542?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.